InvestorsObserver
×
News Home

Is Twist Bioscience Corp (TWST) a Winner in the Diagnostics & Research Industry?

Tuesday, March 12, 2024 10:59 AM | InvestorsObserver Analysts

Mentioned in this article

Is Twist Bioscience Corp (TWST) a Winner in the Diagnostics & Research Industry?

The 56 rating InvestorsObserver gives to Twist Bioscience Corp (TWST) stock puts it near the top of the Diagnostics & Research industry. In addition to scoring higher than 81 percent of stocks in the Diagnostics & Research industry, TWST’s 56 overall rating means the stock scores better than 56 percent of all stocks.

Overall Score - 56
TWST has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on TWST!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Twist Bioscience Corp Stock Today?

Twist Bioscience Corp (TWST) stock is down -1.28% while the S&P 500 has gained 0.9% as of 10:59 AM on Tuesday, Mar 12. TWST is lower by -$0.47 from the previous closing price of $36.86 on volume of 98,845 shares. Over the past year the S&P 500 has risen 33.93% while TWST has gained 116.22%. TWST lost -$3.60 per share the over the last 12 months. Click Here to get the full Stock Report for Twist Bioscience Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App